A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds
Clinical trial NCT06018987 · COMPLETED
Trial details
- NCT number
- NCT06018987
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2025-02-03
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.